#$%^&*AU2012327170A120130822.pdf#####95 ABSTRACT The use of {9-[(R)-2-[[(S)-i[(S)-I(isopropoxvcarbonyl)etil]amino]phenoxvphosphinyl] -rnethoxy ]propyl ]adenine } and the henifinarate form (tenofovir alafenamide hemifumarate) in combination with cobicistat is disclosed. In addition, the combination of tenofovir alafenamide heniifumarate, cobicistat, emtricitabine, and elvitegravir is disclosed. FCHJS WS 8444832vi.doc